TME Pharma N.V. (EPA:ALTME)
France · Delayed Price · Currency is EUR 0.1104
-0.0044 (-3.83%)
Oct 22, 2026, 5:35 PM CEST
TME Pharma Market Cap
TME Pharma has a market cap or net worth of €10.39 million as of October 22, 2026. It is the 40,557th most valuable company in the world and the 523rd biggest in France. Its market cap has increased by 17.67% in one year.
Market Cap
10.39M
Enterprise Value
10.76M
Revenue
n/a
Global Rank
Country Rank
#523 France
PE Ratio
n/a
ChartMarket Cap Chart
Since September 30, 2016, TME Pharma's market cap has decreased from 43.13M to 10.39M, a decrease of -75.91%. That is a compound annual growth rate of -13.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 10.39M | 69.33% |
| Dec 31, 2025 | 6.13M | -13.10% |
| Dec 31, 2024 | 7.06M | 478.85% |
| Dec 29, 2023 | 1.22M | -26.24% |
| Dec 30, 2022 | 1.65M | -90.52% |
| Dec 31, 2021 | 17.44M | -28.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 20.28M |
| MaaT Pharma | 19.22M |
| GenSight Biologics | 17.78M |
| Biophytis | 11.76M |
| Aton | 10.60M |
| Poxel | 9.85M |
| Aelis Farma | 9.68M |
| Advicenne | 9.31M |